9 Reasons Iron Overload Becomes a Hidden Risk Once Periods Stop in Perimenopause
This one genuinely surprised me when I first looked into it. So much of the perimenopause conversation is about deficiency — not enough iron, not enough estrogen, not enough sleep. The idea that iron could quietly tip into excess once periods stop felt counterintuitive. But the research is real, and it explains why cardiovascular risk climbs so sharply after menopause in ways that go beyond just estrogen loss.
Learn more about Rose →Monthly blood loss was the body's primary iron-regulation system
The human body has no efficient mechanism for excreting excess iron — unlike most nutrients, it cannot simply flush it through urine or bile in meaningful amounts. For premenopausal women, menstruation reliably removed roughly 0.5–1 mg of iron per day over the course of a cycle, keeping serum ferritin in a range that protected against oxidative damage. Once periods stop, that exit route closes and iron accumulates by default, not by disease.
Ferritin levels rise measurably within the first years after menopause
Studies tracking women through the menopause transition consistently show serum ferritin climbing significantly in the postmenopausal years, often reaching levels comparable to age-matched men. Research published in the American Journal of Clinical Nutrition found that postmenopausal women had substantially higher ferritin than premenopausal women independent of dietary iron intake. This isn't a gradual drift — it's a predictable physiological shift that happens relatively quickly once cycling ends.
Excess iron generates free radicals that damage arterial walls
Iron is a potent catalyst for oxidative stress through a process called the Fenton reaction, where free iron converts hydrogen peroxide into highly reactive hydroxyl radicals. These radicals attack LDL cholesterol, oxidizing it into a form that triggers arterial plaque formation. This mechanism is one credible explanation for why cardiovascular disease risk in women rises sharply after menopause — not just because estrogen is lost, but because iron accumulation accelerates oxidative damage to blood vessel linings.
The timing of the cardiovascular risk jump mirrors iron accumulation, not just estrogen decline
The Iron Heart Hypothesis, proposed by researcher Jerome Sullivan in the 1980s and supported by subsequent observational data, argues that the divergence in cardiovascular risk between men and premenopausal women is largely explained by women's lower iron stores rather than estrogen alone. Premenopausal women consistently have lower ferritin and lower cardiovascular event rates than men of the same age; after menopause those differences narrow in parallel. The estrogen story is real, but it is almost certainly not the whole story.
The liver is the first organ to absorb excess circulating iron
When iron stores rise beyond the body's immediate needs, the liver acts as the primary depot, storing iron in the form of ferritin and hemosiderin within hepatocytes. Chronically elevated iron in liver tissue promotes oxidative stress, inflammation, and fibrosis through mechanisms that overlap with those seen in non-alcoholic fatty liver disease. Postmenopausal women are at notably higher risk for liver disease than premenopausal women, and elevated iron stores are considered a contributing factor in current hepatology literature.
Continued iron supplementation after periods become irregular may accelerate accumulation
Many women enter perimenopause still taking iron supplements prescribed for heavy menstrual bleeding or past anaemia — a prescription that made complete physiological sense when significant blood loss was ongoing. As cycles become lighter and less frequent, that same supplementation can tip the balance toward excess, adding dietary iron on top of the iron the body is no longer clearing. Checking ferritin levels before continuing any iron supplement is a sensible step that is often skipped in routine care.
Iron overload is largely silent until levels are very high
Mild to moderate iron accumulation produces almost no distinctive symptoms — fatigue is common but is attributed to a dozen other perimenopausal causes, and joint aching, which can be an early sign of iron deposition, is similarly dismissed. Classic hereditary haemochromatosis symptoms like bronze skin discolouration or severe liver enlargement only appear at extreme iron loads that develop over decades. This silence means accumulation goes undetected unless ferritin is specifically tested, which it rarely is in standard perimenopause workups.
Women with genetic variants for haemochromatosis face compounded risk at menopause
Hereditary haemochromatosis, most commonly caused by mutations in the HFE gene, affects roughly 1 in 200 people of Northern European descent — but women with the condition are partially protected during their reproductive years because menstruation compensates for the genetic tendency to over-absorb iron. Menopause removes that compensation entirely, and women who were never symptomatic during their cycling years can develop significant iron loading relatively quickly afterward. Genetic testing and regular ferritin monitoring are particularly important for women with a family history of liver disease, diabetes, or early heart disease.
Ferritin testing is simple, inexpensive, and almost never ordered at routine menopause appointments
A serum ferritin test costs very little and provides a direct window into iron storage status — yet it is not part of standard menopause blood panels in most healthcare systems, which tend to focus on FSH, oestradiol, thyroid function, and lipids. Advocating for ferritin to be included in a routine midlife blood draw is straightforward and well within what any GP or gynaecologist can order. Women who know their ferritin number are in a far better position to make informed decisions about diet, supplementation, and follow-up monitoring.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.